Varsha Damle Email Address

Extensive Experience in Sales Operations and Analytics

Aimmune Therapeutics, Inc., is a clinical-stage biopharmaceutical company developing treatments for life-threatening food allergies. The company's Characterized Oral Desensitization ImmunoTherapy (CODIT) approach is intended to achieve meaningful levels of protection by desensitizing patients with defined, precise amounts of key allergens. Aimmune's first investigational product using CODIT, AR101 for the treatment of peanut allergy, has received the FDA's Breakthrough Therapy Designation for the desensitization of peanut-allergic patients 4-17 years of age and is currently being evaluated in Phase 3 clinical trials in ages 4-55. AR101 is a characterized, regulated, oral biological drug product containing the protein profile found in peanuts.

15+ years of proven pharmaceutical sales analytics, commercial operations, and managed markets analytics experience. Extensive background in salesforce effectiveness functions including Sizing, Targeting, Alignments, Incentive Compensation, KPI Development and Reporting, Data Strategy and Warehousing, Master Data Management, CRM and BI tools.